The PUMA Trial is a Trial of a Single ProHema Modulated-Cord Blood (CB) Unit as Part of a Double CB Transplant in Patients With Hematologic Malignancies.

NCT01627314 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

62

Enrollment

INDUSTRY

Sponsor class

Stopped Business decision

Conditions

Hematologic Malignancies

Interventions

BIOLOGICAL: ProHema-CB
BIOLOGICAL: Untreated CB

Sponsor

Fate Therapeutics